Compounds > tris-(1,10-phenanthroline)ruthenium
Page last updated: 2024-09-04

tris-(1,10-phenanthroline)ruthenium and isoniazid

tris-(1,10-phenanthroline)ruthenium has been researched along with isoniazid in 1 studies

Compound Research Comparison

Studies
(tris-(1,10-phenanthroline)ruthenium)		Trials
(tris-(1,10-phenanthroline)ruthenium)		Recent Studies (post-2010)
(tris-(1,10-phenanthroline)ruthenium)		Studies
(isoniazid)		Trials
(isoniazid)		Recent Studies (post-2010) (isoniazid)
6102121,8159604,493

Protein Interaction Comparison

ProteinTaxonomytris-(1,10-phenanthroline)ruthenium (IC50)isoniazid (IC50)
MyeloperoxidaseHomo sapiens (human)4.85
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv8.29
Putative FAD-containing monooxygenase MymAMycobacterium tuberculosis H37Rv4.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ai, X; He, Z; Shi, B; Xi, J1

Other Studies

1 other study(ies) available for tris-(1,10-phenanthroline)ruthenium and isoniazid

ArticleYear
Chemiluminescence detection of isoniazid using Ru(phen)3(2+)-isoniazid-Ce(IV) system.
    Journal of pharmaceutical and biomedical analysis, 2004, Sep-21, Volume: 36, Issue:1

    Topics: Calibration; Cerium; Isoniazid; Luminescent Agents; Luminescent Measurements; Organometallic Compounds; Phenanthrolines; Reproducibility of Results; Sensitivity and Specificity; Sulfates

2004